2018
DOI: 10.1016/j.actbio.2018.05.010
|View full text |Cite
|
Sign up to set email alerts
|

A review on fabricating tissue scaffolds using vat photopolymerization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
155
0
3

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 192 publications
(158 citation statements)
references
References 225 publications
0
155
0
3
Order By: Relevance
“…LAP has proven to be an appropriate photoinitiator for the PEGDA monomers that are processed in the hybrid AM process. Firstly, because LAP is one of the most successfully used photoinitiators for biocompatible stereolithography [9,29]. Secondly, LAP has a relatively high water solubility and allows for polymerization with visible light (near-UV blue light) which finally leads to a reduced impact on the API compared to photoiniators such as Irgacure ® 2959 (BASF SE, Ludwigshafen, Germany) which need UV light for polymerization [33,34].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…LAP has proven to be an appropriate photoinitiator for the PEGDA monomers that are processed in the hybrid AM process. Firstly, because LAP is one of the most successfully used photoinitiators for biocompatible stereolithography [9,29]. Secondly, LAP has a relatively high water solubility and allows for polymerization with visible light (near-UV blue light) which finally leads to a reduced impact on the API compared to photoiniators such as Irgacure ® 2959 (BASF SE, Ludwigshafen, Germany) which need UV light for polymerization [33,34].…”
Section: Discussionmentioning
confidence: 99%
“…In the medical field, AM techniques are powerful tools for custom-made solutions for surgical instruments, prosthetics, and implants that meet the individual anatomical needs of the patient [3][4][5][6][7]. Furthermore, the technology holds promising potential for tissue engineering and bioprinting as well as organ and disease modeling [8][9][10][11][12]. However, in the pharmaceutical field the technology is still at an early stage [1,5].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The downside of light-assisted manufacturing is that the type of useable photo-polymers are limited and the use of solvents and photoinitiators may leave behind cytotoxic residues which may cause biochemical damage to cellular networks. Recent research has focused on discovering less cytotoxic photoinitiators in combination with more biocompatible, compliant, gel-like materials [33,64]. Printing using visible light mediated by chromophores avoids the use of harmful UV light that can damage encapsulated cells.…”
Section: Biocompatibility Biodegradability and Bioactivitymentioning
confidence: 99%
“…Therefore, GelMA has been extensively used in the last few years. 6,11,13,[15][16][17][18][19][20] Methacrylation allows fast covalent crosslinking in the presence of a photoinitiator and light exposure. 16,21 Methacrylation does not affect the RGD domains and allows the synthesis of materials with tunable mechanical properties.…”
Section: Introductionmentioning
confidence: 99%